関連する実験動画
Updated: Sep 9, 2025
08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.9K
ゾフェノプリル,チモキノンの心臓保護効果と,サイクロフォスファミド誘発の心臓毒性に対するその組み合わせ
Sakar Karem Abdulla1, Ban Mousa Rashid1, Karmand Hamaamin Salih2
1Department of Basic Sciences, College of Pharmacy, University of Sulaimani, Sulaymaniyah, Iraq.
Human & experimental toxicology
|August 30, 2025
まとめ
ゾフェノプリル (Zf) とチモキノン (Thym) は,サイクロフォスファミド (Cyp) 誘発の心臓毒性に対して保護します. Zfは炎症とアポトーシスを減らし,ThymはNF-κBを抑制した. 抗酸化能力を高めました
科学分野:
- 薬理学について
- 毒理学について
- 心臓病科
背景:
- シクロフォスファミド (Cyp) は臓器毒性,特に心臓毒性を引き起こすことが知られている.
- 薬剤による心臓損傷に対する 保護剤の調査は 患者の安全のために極めて重要です
研究 の 目的:
- ゾフェノプリル (Zf),チモキノン (Thym),およびその組み合わせが,ラットモデルにおけるCyp誘発性心臓毒性の軽減における有効性を評価する.
主な方法:
- 30匹のラットはコントロール,Cyp,Zf,Thym,Zf + Thymの5つのグループに分けられました.
- 治療は19日間経口投与され,関連する群では17日に1回のIP用量Cypを投与した.
- 心臓のバイオマーカー (トロポニンT,CK-MB),炎症マーカー (hs-CRP,NF-κB),アポプトシスマーカー (カスペーゼ-3),抗酸化能力 (TAC) を評価した.
主要な成果:
- Cypの投与は心臓損傷マーカーを著しく増加させ,組織病理学的変化を引き起こした.
- ZfとThymは,単独でも組み合わせても,CK- MBのレベルを低下させた.
- Zfは抗炎症作用 (hs- CRPの低下) と抗アポプトシス作用を示し,ThymはNF- kBを抑制した.
- 併用療法により,総抗酸化能力 (TAC) が有意に上昇した.
結論:
- ゾフェノプリルとチモキノンは,異なるメカニズムを通じて,サイクロフォスファミド誘発の心臓毒性に対する心臓保護を提供します.
- Zfは抗炎症および抗アポプトシス経路を通して作用し,ThymはNF-κBシグナル伝達を標的とする.
- 併用療法では抗酸化能力が向上するが,他の評価パラメータでは追加的な効果は見られなかった.
関連する概念動画
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:26Heart Failure Drugs: Inotropic Agents
717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75
01:22Heart Failure Drugs: Diuretics
483
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
483
01:29Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
867
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
867